Parabilis Medicines files Form 3 initial beneficial ownership statement for Guy Levy

Parabilis Medicines, Inc.

Parabilis Medicines, Inc.

PBLS

0.00
  • Parabilis Medicines Form 3 filed for Guy Levy, flagged as a 10% owner, tied to Soleus Capital-managed entities.
  • Reporting group disclosed indirect holdings of Series F Preferred Stock convertible into 527,070 common shares.
  • Conversion or exercise price listed at USD 9.48 per share.
  • Event date was June 9, 2026; filing signed June 29, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parabilis Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-072925), on June 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.